CD4 and systemic lupus erythematosus: Increased glycolysis has been noted in CD4+ T cells from individuals with SLE and in mouse models of lupus, and furthermore, treatment of this abnormally enhanced glycolysis in mice resulted in a shift of immunophenotype toward that of healthy controls (33).